Symbol | Exchange | Currency |
|---|
Omega Healthcare Investors (OHI) says three operators accounting for about 9% of the company’s estimated contractual rent and mortgage payments in Q3 2021 have stopped making...
Omega Flex (NASDAQ:OFLX) declares $0.30/share quarterly dividend, in line with previous.Forward yield 0.82%Payable Oct. 4; for shareholders of record Sept. 27; ex-div Sept.
By Samuel IndykInvesting.com – Omega Diagnostics (LON:ODX) shares were trading lower on Wednesday morning after the company provided an update ahead of its Annual General Meeting...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Sell | Strong Sell | Sell |
| Technical Indicators | Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
| Summary | Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.23 | 0.00 | 0.00 | +0.0050 | +2.27% | 4.89M | London | |||
| 985.60 | 1,000.00 | 979.40 | -13.80 | -1.38% | 2.04M | London | |||
| 28.25 | 29.25 | 28.15 | -0.55 | -1.91% | 976.74K | London | |||
| 103.00 | 105.50 | 103.00 | +0.50 | +0.48% | 470.34K | London | |||
| 585.00 | 595.80 | 577.20 | -8.80 | -1.48% | 2.11M | London | |||
| 6.05 | 11.11 | 6.30 | 0.00 | 0.00% | 0.00 | London | |||
| 4,775.50 | 4,822.50 | 4,734.50 | -27.5 | -0.57% | 4.16M | London | |||
| 51.86 | 54.36 | 51.52 | +0.64 | +1.25% | 19.11M | London | |||
| 61.00 | 61.00 | 61.00 | +0.50 | +0.83% | 39.23K | London | |||
| 203.20 | 207.90 | 202.70 | -4.00 | -1.93% | 24.69M | London | |||
| 186.32 | 188.50 | 185.54 | -1.46 | -0.78% | 33.86M | London | |||
| 278.70 | 283.20 | 277.90 | -3.10 | -1.10% | 15.70M | London | |||
| 769.80 | 791.00 | 767.40 | -22.20 | -2.80% | 841.69K | London | |||
| 918.00 | 929.50 | 911.50 | -2.50 | -0.27% | 433.78K | London | |||
| 157.00 | 157.00 | 152.00 | +3.50 | +2.28% | 1.31M | London |
Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.